T
Power Law company profile
Tarsus Pharmaceuticals
Biotech & Life Sciences · Irvine, United States · Founded 2017 · IPO 2020 Unicorn
Valuation
$2.27B
Market cap · Apr/2026
Revenue
$451M
Latest reported FY
Global footprint
Where Tarsus Pharmaceuticals has talent and traffic
Web traffic by country
38K
monthly visits
across markets
across markets
🇺🇸 United States92.1%
🇨🇦 Canada6.3%
🇮🇳 India1.1%
🇬🇧 United Kingdom0.8%
🇯🇵 Japan0.3%
Patent intelligence
$8M patent portfolio · 4 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.
Estimated portfolio value
$8M
0.36% of market cap · 20.1× smaller than top peer Amicus Therapeutics ($164M)
4 active patent families
Where Tarsus Pharmaceuticals innovates
PharmacologyOptometryBlepharitisPharmaceutical medicineDisease
Tech-focus vs peers
Where Tarsus Pharmaceuticals concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Tarsus Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Tarsus Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.